XML 43 R24.htm IDEA: XBRL DOCUMENT v3.22.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2021
Income Tax Disclosure [Abstract]  
Summary of Statutory Tax Rates Applicable to Income of Company and Subsidiaries

The Company is taxed according to U.S. federal and state tax laws and Israeli tax laws. The statutory tax rates applicable to the income of the Company and its subsidiaries for the periods presented are as follows:

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

89bio, Inc.

 

 

21

%

 

 

21

%

89Bio Ltd.

 

 

23

%

 

 

23

%

89bio Management, Inc.

 

 

21

%

 

 

21

%

UAB 89bio Lithuania

 

 

15

%

 

 

15

%

Summary of Income Tax Benefit (Expense)

The income tax benefit is comprised of (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

Current:

 

 

 

 

 

 

 

 

Federal

 

$

 

 

$

(11

)

State

 

 

(2

)

 

 

1

 

Foreign

 

 

(1

)

 

 

 

Total

 

 

(3

)

 

 

(10

)

 

 

 

 

 

 

 

 

 

Deferred:

 

 

 

 

 

 

 

 

Federal

 

 

150

 

 

 

69

 

Total

 

 

150

 

 

 

69

 

Income tax benefit

 

$

147

 

 

$

59

 

Summary of Components of Deferred Tax Assets Significant components of the Company’s deferred tax assets for the periods presented are as follows (in thousands):

 

 

As of December 31,

 

 

 

2021

 

 

2020

 

U.S. net operating loss carryforwards

 

$

29,094

 

 

$

11,342

 

Research and development expenses

 

 

6,529

 

 

 

5,392

 

Israel net operating loss carryforwards

 

 

4,262

 

 

 

3,978

 

Stock-based compensation

 

 

1,969

 

 

 

610

 

Accrued expenses

 

 

220

 

 

 

635

 

Other

 

 

191

 

 

 

48

 

Total deferred tax assets

 

 

42,265

 

 

 

22,005

 

Less: valuation allowance

 

 

(42,046

)

 

 

(21,936

)

Net deferred tax assets

 

$

219

 

 

$

69

 

 

Summary of Loss from Operations Before Taxes on Income

The Company recorded a loss from operations, before income tax for the periods presented as follows (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

United States

 

$

(91,141

)

 

$

(58,760

)

Lithuania

 

 

10

 

 

 

(73

)

Israel

 

 

862

 

 

 

9,275

 

Net loss before income tax

 

$

(90,269

)

 

$

(49,558

)

Summary of Reconciliation of Income Tax Benefit (Expense) Statutory Tax Rate to Effective Tax Rate

The reconciliation of income tax benefit based on the statutory tax rate to the effective tax rate for the periods presented is as follows (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

Income tax benefit computed at statutory rates

 

$

18,757

 

 

$

8,285

 

Change in valuation allowance

 

 

(20,111

)

 

 

(11,914

)

Foreign rate differential

 

 

(19

)

 

 

1,671

 

Change in Israel effective tax rate due to the 2019

   reorganization

 

 

(2

)

 

 

647

 

Research and development credits, net of

   uncertain tax position

 

 

1,331

 

 

 

815

 

Other

 

 

191

 

 

 

555

 

Income tax benefit

 

$

147

 

 

$

59